NOA rizatriptan (as benzoate) 10 mg orodispersible tablet blister pack

Riik: Austraalia

keel: inglise

Allikas: Department of Health (Therapeutic Goods Administration)

Osta kohe

Avaliku hindamisaruande Avaliku hindamisaruande (PAR)
26-11-2017

Toimeaine:

rizatriptan benzoate, Quantity: 14.53 mg (Equivalent: rizatriptan, Qty 10 mg)

Saadav alates:

Medis Pharma Pty Ltd

INN (Rahvusvaheline Nimetus):

rizatriptan benzoate

Ravimvorm:

Tablet, orally disintegrating

Koostis:

Excipient Ingredients: crospovidone; calcium silicate; aspartame; microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; mannitol; Flavour

Manustamisviis:

Oral

Ühikuid pakis:

3, 6, 2

Retsepti tüüp:

(S4) Prescription Only Medicine

Näidustused:

NOA is indicated for the acute treatment of migraine attacks with or without aura.

Toote kokkuvõte:

Visual Identification: White, round, flat, bevel-edged tablet embossed with "IZ 10" on one side and plain on the other side; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

Volitamisolek:

Licence status A

Loa andmise kuupäev:

2015-02-19